Off-label treatment in diabetic retinopathy

Autores

  • Luis Jesuino de Oliveira Andrade Universidade Estadual de Santa Cruz
  • Larissa Santos França Hospital Calixto Midlej Filho - Itabuna - Bahia.
  • Luciana Santos França Hospital Calixto Midlej filho - Itabuna - Bahia.
  • Alcina Maria Vinhaes Bittencourt Faculdade de Medicina - Universidade Federal da Bahia.
  • Caroline Santos França Hospital São Rafael - Salvador - Bahia

DOI:

https://doi.org/10.9771/cmbio.v13i1.9024

Palavras-chave:

Diabetic retinopathy. Off-label use. Therapy. Diabetes mellitus.

Resumo

Introduction: The prescribing a drug without the indications for which the drug was originally approved by regulators is internationally known as prescribing “off-label”. Objective: To describe the off-label therapy in diabetic retinopathy, reported international scientific literature, through an integrative bibliographical review. Method: Integrative review by searching the Medline international database for review of manuscripts. Results: A total 852 scientific productions were identified, and 37 studies were selected by contain information about the off-label therapy in diabetic retinopathy. Conclusion: The practice of off-label prescribing in diabetic retinopathy has benefits, and in some situations is the only treatment available.

Downloads

Não há dados estatísticos.

Downloads

Publicado

2014-07-21

Como Citar

de Oliveira Andrade, L. J., Santos França, L., Santos França, L., Vinhaes Bittencourt, A. M., & Santos França, C. (2014). Off-label treatment in diabetic retinopathy. Revista De Ciências Médicas E Biológicas, 13(1), 78–84. https://doi.org/10.9771/cmbio.v13i1.9024

Artigos mais lidos pelo mesmo(s) autor(es)